Hum. Reprod. Advance Access originally published online on April 16, 2007
Human Reproduction 2007 22(7):1925-1931; doi:10.1093/humrep/dem081
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The number of small antral follicles (2–6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population
1 Department of Obstetrics and Gynaecology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands 2 Department of Obstetrics and Gynaecology, Meander Medical Center, Amersfoort, The Netherlands 3 Office for Medical Technology Assessment, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands 4 Department of Obstetrics and Gynaecology, Academic Medical Center, Amsterdam, The Netherlands
5 Correspondence address. Tel: +31 (0) 50 3613152; Fax: +31 (0) 50 3611806; E-mail: a.hoek{at}og.umcg.nl
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
BACKGROUND: Ovarian reserve is related to age and can be estimated by ovarian reserve tests (ORTs), such as antral follicle count (AFC) and various endocrine parameters. The endocrine function of a follicle is related to its size. The aim of this study is to evaluate which sizes of antral follicles are most closely correlated with age and the outcome of endocrine ORTs.
METHODS: In total 474 subfertile, ovulatory patients, recruited from two fertility centers in The Netherlands, participated in this prospective cohort study. The following ORTs were performed: AFC (follicles from 2 to 10 mm), basal FSH, basal inhibin B (bInhB), clomiphene citrate challenge test and inhibin B after stimulation with clomiphene citrate.
RESULTS: The number of small follicles (2–6 mm) declined with age; the number of larger follicles (7–10 mm) remained constant. Independent of age, the number of small follicles was significantly related to all ORTs (P < 0.001, except bInhB P = 0.005). The number of larger follicles was only significantly related to bInhB (P = 0.009).
CONCLUSIONS: The number of small antral follicles (2–6 mm) is significantly related to age and also, independent of age, to all endocrine ORTs tested, suggesting the number of small antral follicles represents the functional ovarian reserve.
Key words: antral follicle count/antral follicle size/female age/ovarian reserve test
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
Reproductive ageing is considered to be the consequence of a decrease in quantity and quality of the ovarian follicle pool (Te Velde and Pearson, 2002
). Autopsy studies in human ovaries show that the number of follicles decreases rapidly with female age, starting in foetal life and continuing until after menopause (Block, 1952; Gosden and Faddy, 1994; Gougeon et al., 1994). However, between women of the same chronological age the quantitative ovarian reserve may vary substantially (Broekmans et al., 2004). To assess the individual quantitative ovarian reserve, during the last decades various ovarian reserve tests (ORTs) have been developed, which can roughly be divided into three groups. Most ORTs measure early follicular phase hormone levels, such as serum FSH (Scott and Hofmann, 1995; Te Velde et al., 1997), estradiol (E2) (Licciardi et al., 1995; Evers et al., 1998) and inhibin B (Soules et al., 1998; Welt et al., 1999). Recently, anti-Müllerian hormone (AMH) has been added as a promising ORT (De Vet et al., 2002; Fanchin et al., 2003; Van Rooij et al., 2005). Dynamic ORTs assess the endocrine response of the ovaries to exogenous stimuli. Examples of dynamic tests are the clomiphene citrate challenge test (CCCT) (Nader and Berkowitz, 1991; Scott et al., 1993), the exogenous FSH ovarian reserve test (Fanchin et al., 1994) and the GnRH agonist stimulation test (Winslow et al., 1991; Ranieri et al., 1998). The third group of ORTs consists of sonographic parameters, such as the antral follicle count (AFC) (Ng et al., 2003; Scheffer et al., 2003) and measurement of the ovarian volume (Syrop et al., 1995; Wallace and Kelsey, 2004).
The way an AFC is performed differs between centers. Most often follicles of 2–5 mm or 2–10 mm are counted. Research in various fertile and IVF-treated populations demonstrates a close relation of AFC with age (Reuss et al., 1996; Chang et al., 1998; Scheffer et al., 1999; Muttukrishna et al., 2005). In the studies commenting on AFC and age, only total AFC is calculated and the different sizes of the individual follicles are not reflected on. The distinction of various size categories may be relevant since several studies show that the endocrine function of a follicle is related to its size. For instance, AMH is mainly produced by pre-antral and smaller antral follicles up to 4–6 mm (Weenen et al., 2004). In various studies, AMH is strongly associated with total AFC (De Vet et al., 2002; Fanchin et al., 2003; Van Rooij et al., 2005). These data suggest that the number of smaller antral follicles up to 6 mm reflects ovarian reserve better than the total AFC, if follicles of 2–10 mm are counted. Magoffin and Jakimiuk (1997) show that the production of inhibin B by the antral follicles increases with the size of the follicle up to 13 mm. Thus, the larger antral follicles may also be an important reflection of the remaining follicle pool. The relation between dynamic endocrine ORTs and antral follicle size has not been studied.
As part of a prospective study addressing the predictive value of ORTs for spontaneous and treatment-related pregnancy in a subfertile population, we examined which sizes of antral follicles are most closely associated with female age and which sizes of antral follicles determine the outcome of various endocrine ORTs.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
Study population
From December 1999 to July 2003, patients were recruited at the fertility centers of the University Medical Center Groningen, a tertiary fertility center, and the Martini Hospital, a teaching hospital, both in Groningen, The Netherlands. Patients were asked to participate after basal subfertility evaluation including sonographic cycle analysis and measurement of midluteal progesterone, semen analysis, post-coital test and hysterosalpingography (HSG). Inclusion criteria were: (i) subfertility for at least 12 months, (ii) regular ovulatory cycle with a midluteal progesterone of >30 nmol/l and a cycle length between 21 and 42 days, (iii) at least one patent Fallopian tube at HSG and/or laparoscopy, (iv) semen analysis of the partner with a total motile count (volume x concentration x motility) >1 x 106, (v) no ovarian cysts, (vi) no history of gynaecological, hypothalamic or pituitary malignancy, (vii) no liver insufficiency, (viii) no history of thrombo-embolic processes and (ix) no sexual disorder leading to a coitus frequency of less than once a month. According to the inclusion criteria, 732 patients were eligible for this study (see flowchart, Fig. 1). One hundred thirty-six patients did not want to be enrolled in the study, and 27 patients were not asked to participate due to inadvertency. Fifty-four patients were excluded secondarily since eventually they did not meet the inclusion criteria; the main reason for this was two-sided tubal pathology on laparoscopy because of adhesions or severe endometriosis, despite one or two patent tubes on HSG. Furthermore, 32 patients became pregnant just after inclusion but before undergoing ORTs and 9 patients did not return after inclusion. In total, 474 patients actually participated, 353 in the University Medical Center Groningen and 121 in the Martini Hospital. Informed consent was obtained from all participants. The study protocol was reviewed and approved by the Medical Ethics Committee for Research Projects of both participating hospitals.
|
Study protocol
After inclusion, patients visited the outpatient clinic in the early follicular phase of the menstrual cycle (cycle day 2, 3 or 4). Transvaginal ultrasound was performed to measure size and number of the antral follicles as well as the volume of both ovaries. Peripheral blood was drawn to measure levels of basal FSH (bFSH) and basal inhibin B (bInhB). Subsequently, patients took 100 mg clomiphene citrate on cycle day 5–9. One week after the first visit, the transvaginal ultrasound was repeated and blood samples were drawn again to measure stimulated FSH and stimulated inhibin B levels (respectively, sFSH and sInhB in the CCCT). The result of the CCCT was defined as bFSH + sFSH.
Transvaginal ultrasound measurements
The volume of each ovary was determined by measuring the three perpendicular diameters and applying the formula for the volume of an ellipsoid: (L x W x D x 
)/6; the volumes of both ovaries were added for the total ovarian volume (Syrop et al., 1995; Scheffer et al., 1999). All follicles of 2–10 mm were counted and measured in two dimensions. The mean of these measurements was taken to be the follicle size. The numbers of follicles from both ovaries were added for the total AFC. All transvaginal ultrasound measurements were performed by four skilled gynaecologists using a 7.5 MHz vaginal probe on an Aloka SSD-1700 US machine. Several studies demonstrate that the intra-observer and inter-observer reproducibility of antral follicle measurements is adequate (Pache et al., 1990; Scheffer et al., 2002; Jayakaprasan et al., in press). Intra-observer and inter-observer coefficients were not determined in this study.
Hormone assays
For measurements of concentrations of FSH and inhibin B, serum was stored at –20°C until processing. Serum FSH levels were measured by fluorimmunometric determination on the AutoDelfia (Wallac/Perkin Elmer, Turku, Finland). For FSH, the inter-assay coefficient of variation was 3.7%, the sensitivity <0.05 IU/l. The lower limit of detection was 0.03 IU/l. The standard of the FSH assay was calibrated against the World Health Organization Second International Reference Preparation for human FSH (78/549). Inhibin B concentrations were assayed with an enzyme-linked immunosorbent assay from Serotec (Kidlington, Oxford, UK). The inter-assay coefficient of variation for inhibin B was 11% and the sensitivity was <10 pg/ml. The lower limit of detection was 5 pg/ml.
Statistical analysis
Data were analysed with the Statistical Package for Social Sciences (SPSS 12.0 for Windows. Inc., Chicago, IL, USA). Patient characteristics and results of the ORTs are presented as median values with 10th–90th percentiles or as numbers with percentages. The correlation between the various parameters is expressed as Spearman's correlation coefficient (r). Regression analysis was used to study the influence of age and various sizes of antral follicles on the endocrine variables. Statistical significance was considered to be reached at a P-value < 0.05.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
The study population consisted of 474 women. Patient characteristics are shown in Table 1. At the time of the CCCT median female age was 32.5 years, median duration of subfertility was over 2 years and about two-third of the women had a primary subfertility. Most couples were diagnosed with unexplained subfertility (51.3%) or male factor (44.9%). In Table 2, the results of the various ORTs are shown.
|
|
The various endocrine ORTs were not determined at one exact point in the cycle, but within a period of three cycle days. We analysed the differences between the results of the tests performed on cycle days 2, 3 and 4 and found two significant differences. bInhB values on cycle day 2 were significantly lower than bInhB values on cycle days 3 and 4 (P-value < 0.001). It is known that serum levels of inhibin B rise in the early follicular phase up to a peak level around cycle day 5 or 6 (Groome et al., 1996
). Therefore, it is not surprising that inhibin B levels on cycle day 2 are lower than on cycle days 3 and 4. We then analysed the correlation between the results of the endocrine ORTs in groups per cycle day with age, AFC, follicle size and with each other. The correlation coefficients within the groups per cycle day were comparable to those in the total group, also for bInhB. We therefore analysed the group as a whole despite the differences mentioned.
Table 3 shows a correlation matrix of the ORTs and age. Age is significantly negatively correlated with AFC (r = – 0.298; P < 0.01) and total ovarian volume (r = –0.183; P < 0.01) and positively correlated with bFSH (r = 0.201; P < 0.01) and CCCT (r = 0.219; P < 0.01). Age is not significantly related to bInhB and sInhB in the CCCT. AFC is significantly correlated with all ORTs performed.
|
To answer the question of which size of antral follicles is most closely associated with age, the number of antral follicles was correlated with age for each size separately. The number of follicles measuring 2, 3, 4, 5 and 6 mm all declined with age, whereas the number of follicles measuring 7 mm or more did not (data not shown). These results were combined to two categories, i.e. small antral follicles (2–6 mm) and larger antral follicles (7–10 mm). Figure 2 shows that total AFC and the number of small follicles decline with age, whereas the number of larger follicles remains quite constant with increasing age up to 45 years. The curves of AFC and number of small antral follicles versus age mimic each other; they are not linear but show a steeper decline when female age reaches the second half of the fourth decade. Non-linear spline regression analysis was used to detect transition points between the horizontal part and the steeper part of the curve for follicles 2–6 mm in size. However, no statistically significant change in slope was found, neither for true nor for log transformed values.
|
In view of the findings in Fig. 2, the correlation between the same two categories of small and larger antral follicles and the endocrine ORTs and age was explored (Table 4). The number of small antral follicles (2–6 mm) is significantly correlated with all endocrine ORTs. The larger follicles (7–10 mm) correlate only with total ovarian volume and bInhB.
|
Since age is related to number and size of the antral follicles as well as the outcome of various ORTs, regression analysis was performed to determine which size of antral follicles is most closely correlated with the outcome of endocrine ORTs, independent of age. In Table 5, the results of the regression analysis are shown, depicting the non-standardized correlation coefficient B and its 95% confidence interval (CI) for each individual variable. The total number of small antral follicles (2–6 mm) is significantly related to all endocrine ORTs, whereas the number of larger follicles (7–10 mm) is only significantly related to bInhB. Repeated analyses with single 1 mm follicle size categories as independent variables instead of grouped categories confirmed the influence of smaller size follicles, but this could not be narrowed to a specific size category (data not shown).
|
Since both age and number of small antral follicles are significantly correlated with bFSH and CCCT (Table 5), standardized correlation coefficients (
) were computed to compare the strength of these correlations (not shown in table). The relation of the number of small antral follicles with bFSH is slightly stronger than the relation of age with bFSH (respectively = –0.209 and = 0.188). Similarly, the number of small antral follicles is slightly more strongly related to the CCCT than age (respectively, = –0.217 and = 0.198). |
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
This study demonstrates that the number of small antral follicles (2–6 mm) declines with age, whereas the number of larger follicles (7–10 mm) remains nearly constant. Irrespective of female age, the number of small antral follicles is strongly correlated with the outcome of various basal and dynamic endocrine ORTs, whereas the number of larger antral follicles is not. The relations with both female age and endocrine ORTs suggest that the number of small antral follicles represents the functional ovarian reserve.
The number of antral follicles as seen on ultrasound is assumed to depend on the size of the primordial follicle pool from which they are recruited. This phenomenon has been described in rodents by Krohn (1967) and Krarup et al. (1969): the more primordial follicles are available, the more follicles will grow. In humans, this may explain why the AFC is an adequate ORT. Research in various fertile and IVF-treated populations demonstrates a close correlation of AFC with age (Reuss et al., 1996; Chang et al., 1998; Scheffer et al., 1999; Muttukrishna et al., 2005). In our subfertile population, the number of follicles measuring 2 up to 6 mm all decline with age; the number of larger follicles (7–10 mm) per woman is low and remains relatively constant with age. In line with our results, Scheffer et al. (1999) described in a fertile population a steeper yearly decline in the number of small antral follicles (2–5 mm) than for larger follicles (6–10 mm).
As a result of our findings, the fitted curve of the number of small follicles versus age mimics the fitted curve of the total AFC versus age. The pattern of decline of follicle number and AFC with age has been studied extensively. From autopsy studies of ovarian tissue a model of follicle disappearance from birth to menopause was obtained, showing a biphasic pattern with a steeper decline of follicles after the age of 37.5 years (Faddy et al., 1992). Scheffer et al. (1999) found the same pattern of decline of AFC with age, assessed by ultrasound in a proven fertile population. Thus, AFC was considered to be a reflection of the total follicle pool. The biphasic pattern of the decline of follicles has been debated strongly, among others by Leidy et al. (1998). They state that the biphasic pattern is an artefact of the statistical methods used. Reuss et al. (1996) and Ng et al. (2003) did not find a biphasic pattern either in the decline of AFC with age in different populations. Broekmans et al. (2004) reanalysed the data from the earlier study of their group (Scheffer et al., 1999, as described above) and proposed a linear decline of antral follicles with age. Our data show a decline of total AFC with age with a steeper decline starting in the years preceding the age of 40. However, spline regression did not reveal a statistically significant change in slope. These results subscribe to the findings of Tufan et al. (2004) that there is no single point after which the decline in follicles increases, but that indeed there is a general trend of an accelerating decline of follicles when female age reaches the second half of the fourth decade. The shape of the curve may partly explain why the correlation coefficient of AFC with age in the fertile population of Scheffer et al. (2003) (r = 0.68) is higher than in our population (r = 0.298). Since median age in their group is 38.0 years, many participants are represented in the steeper part of the curve. Since correlation assumes a linear relation between two variables, it is expected that the correlation coefficient in the group of Scheffer is higher than in our younger population (median age of 32.5 years), because of the difference in age distribution. Moreover, the findings of Kline et al. (2005) show that the correlation of AFC and age is stronger with advancing age. This may be explained by the fact that the reproducibility of the AFC declines when higher follicle counts are observed (Scheffer et al., 2002), which is more often the case in younger women. However, a stronger correlation of AFC and age with advancing age might also be a biological phenomenon.
Our data show that the smaller antral follicles (2–6 mm) correlate not only with age, but also independently correlate with the results of the various endocrine ORTs. Age and the endocrine ORTs used are no gold standard for ovarian reserve. However, since the various tests used in our study are all—independently of each other—related to the number of small follicles, we believe that our data support the conclusion that the number of small follicles represents the ovarian reserve. The larger follicles only correlate with ovarian volume, which is biologically plausible, and bInhB. The relation of bInhB with both small and larger antral follicles corresponds with the fact that inhibin B is produced by pre-antral and antral follicles, with concentrations in the follicular fluid rising with the size of the follicle from 4 up to 13 mm (Magoffin and Jakimiuk, 1997, Welt and Schneyer, 2001). The fact that the number of larger follicles does not relate to age and most ORTs may be explained by the limited variation in number of larger follicles per woman, precluding statistical relations with any parameter. The lack of a clear correlation with ovarian reserve may also be explained biologically, if the larger follicles represent follicles on their way to dominance. The process of selection of the dominant follicle may well be independent of the size of the antral follicle pool it is chosen from. This may be true especially for our study population, since the participants were selected on having an ovulatory cycle, proven by sonographic cycle analysis and sufficient midluteal progesterone. Women with cycle disturbances caused by a profound diminished ovarian reserve were excluded from our study beforehand. Selection of the dominant follicle is assumed to take place between cycle days 1 and 5 (Gougeon and Lefèvre, 1983) or between cycle days 3 and 10 (Pache et al., 1990). This variation in moment of selection may explain why in 31% of the (ovulatory) women no larger follicle was seen when the AFC was performed (cycle days 2–4).
Our data suggest that, when performing an AFC, follicles up to 6 instead of 10 mm should be counted. It is unlikely that this will considerably change the clinical accuracy of the AFC, since total AFC (2–10 mm) is mainly defined by the number of small antral follicles (2–6 mm). The AFC of 2–6 mm may be especially useful for research purposes or when a clinical cut-off point is used, e.g. when the start of treatment depends on a minimum number of follicles available.
All endocrine variables are more strongly associated with the number of small antral follicles than with age. This finding corresponds to the biological function of the antral follicles: the granulosa cells of the antral follicle pool produce E2 and inhibin B and, via feedback mechanisms, indirectly determine pituitary FSH secretion.
A promising new endocrine marker for ovarian reserve, AMH, was unfortunately not measured in our study. It has been described that AMH is closely related to both female age and AFC (De Vet et al., 2002; Fanchin et al., 2003; Van Rooij et al., 2005) and that AMH is especially secreted by smaller follicles (Weenen et al., 2004; Fanchin et al., 2005). These findings subscribe to our hypothesis that the smaller antral follicles actually represent the functional ovarian reserve.
A notable additional finding in our subfertile population concerns bFSH and CCCT. In line with other studies, bFSH and CCCT correlate with both female age and AFC (Nader and Berkowitz, 1991; Scott et al., 1993; Ng et al., 2003; Scheffer et al., 2003) Interestingly, there is no substantial difference in the correlations of bFSH and CCCT with female age (respectively, r = 0.201 and r = 0.219). Similarly, the correlations of bFSH and CCCT with AFC are comparable (respectively r = –0.288 and r = –0.296). These results suggest that the CCCT has no additional value as an ORT over bFSH alone. This issue has been addressed in several clinical studies examining the value of CCCT compared with bFSH in predicting ovarian response to hyperstimulation or pregnancy chances, spontaneously or after IVF-treatment. Some studies state that the CCCT does provide extra clinical information over bFSH alone (Navot et al., 1987; Tanbo, 1992, Ng et al., 2005), but other studies cannot confirm these findings (Van der Stege and Van der Linden, 2001; Kwee et al., 2003; Jain et al., 2004; Hendriks et al., 2005). In a future evaluation, we will assess the predictive value of these tests for the occurrence of spontaneous and assisted reproduction technique-related pregnancy in our study population of subfertile ovulatory women. It is known that both bFSH and CCCT can vary substantially per cycle in the same woman (Hannoun et al., 1998, Kwee et al., 2004), which might hamper the interpretation of these tests.
In conclusion, the results of our study suggest that, independent of age, the number of small antral follicles measuring 2–6 mm represents the functional quantitative ovarian reserve. Therefore, we propose that if an AFC is performed, only follicles sized 2–6 mm could be counted and used for the interpretation of the outcome of endocrine ORTs. Furthermore, our data suggest that bFSH might have the same clinical value as CCCT, since there is no substantial difference between their correlations with, respectively, female age and AFC. Only clinical use of these tests can confirm or reject this assumption. Research in different populations, e.g. fertile women or women indicated for IVF, is needed to assess whether our results are valid outside our population of subfertile ovulatory women.
|
Acknowledgements |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
We thank Dr P.F.J. Donderwinkel for the inclusion of patients and the performance of ovarian reserve tests in the Martini Hospital Groningen. This study was supported by grants from the University Medical Center Groningen and Organon, the Netherlands. Parts of these data were presented on a poster at the 61st Annual Meeting of the American Society for Reproductive Medicine, 2005, Montreal, Canada.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionAcknowledgementsReferences |
|---|
Block E. Quantitative morphological investigations of the follicular system in women. Variations at different ages. Acta Anatomica (1952) 14:108–123.[Web of Science][Medline]
Broekmans FJM, Faddy MJ, Scheffer GJ, et al. Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause (2004) 11:607–614.[CrossRef][Medline]
Chang MY, Chiang CH, Hsieh TT, et al. Use of the antral follicle count to predict outcome of assisted reproductive technologies. Fertil Steril (1998) 69:505–510.[CrossRef][Web of Science][Medline]
De Vet A, Laven JSE, De Jong FH, et al. Antimüllerian hormone serum levels: a putative marker for ovarian ageing. Fertil Steril (2002) 77:357–362.[CrossRef][Web of Science][Medline]
Evers JLH, Slaats P, Land JA, et al. Elevated levels of basal estradiol-17ß predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilisation. Fertil Steril (1998) 69:110–114.
Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod (1992) 7:1342–1346.
Fanchin R, De Ziegler D, Olivennes F, et al. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting ‘poor responders’ in in-vitro fertilization. Hum Reprod (1994) 9:1607–1611.
Fanchin R, Schonäuer LM, Righini C, et al. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod (2003) 18:323–327.
Fanchin R, Louafi N, Méndez Lozano D, et al. Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status. Fertil Steril (2005) 84:167–173.[CrossRef][Web of Science][Medline]
Gosden RG, Faddy MJ. Ovarian aging, follicular depletion and steroidgenesis. Exp Gerontol (1994) 29:265–274.[CrossRef][Web of Science][Medline]
Gougeon A, Lefèvre B. Evolution of the diameters of the largest healthy and atretic follicles during the human menstrual cycle. J Reprod Fertil (1983) 69:497–502.
Gougeon A, Ecochard R, Thalabard JC. Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol Reprod (1994) 50:653–663.[Abstract]
Groome NG, Illingworth PJ, O'Brien M, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab (1996) 81:1401–1405.[Abstract]
Hannoun A, Abu Musa A, Awwad J, et al. Clomiphene citrate challenge test: cycle to cycle variability of cycle day 10 follicle stimulating hormone level. Clin Exp Obstet Gynecol (1998) 25:155–156.[Medline]
Hendriks DJ, Broekmans FJM, Bancsi LFJMM, et al. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve. Hum Reprod (2005) 20:163–169.
Jain T, Soules MR, Collins JA. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril (2004) 82:180–185.[CrossRef][Web of Science][Medline]
Jayaprakasan K, Walker KF, Clewes JS, et al. The interobserver reliability of off-line antral follicle counts made from stored three-dimensional ultrasound data: a comparative study different measurement techniques. In: Ultrasound Obstet Gynecol (2007) 29:335–341.[CrossRef][Medline]
Kline J, Kinney A, Kelly A, Reuss ML, et al. Predictors of antral follicle count during the reproductive years. Hum Reprod (2005) 20:2179–2189.
Krarup T, Pedersen T, Faber M. Regulation of oocyte growth in the mouse ovary. Nature (1969) 224:187–188.[CrossRef][Medline]
Krohn PL. Factors influencing the number of oocytes in the ovary. Arch Anat Micros Morphol Exp (1967) 56:151–159.
Kwee J, Elting MW, Schats R, et al. Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study. Hum Reprod (2003) 18:1422–1427.
Kwee J, Schats R, McDonnel J, et al. Intercycle variability of ovarian reserve tests: results of a prospective randomized study. Hum Reprod (2004) 19:590–595.
Leidy LE, Godfrey LR, Sutherland MR. Is follicular atresia biphasic? Fertil Steril (1998) 70:851–859.[CrossRef][Web of Science][Medline]
Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril (1995) 64:991–994.[Web of Science][Medline]
Magoffin DA, Jakimiuk AJ. Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women. Hum Reprod (1997) 12:1714–1719.
Muttukrishna S, McGarrigle H, Wakim R, et al. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG (2005) 112:1384–1390.[Web of Science][Medline]
Nader S, Berkowitz AS. Use of the hormonal response to clomiphene citrate as an endocrinological indicator of ovarian ageing. Hum Reprod (1991) 6:931–933.
Navot D, Rosenwaks Z, Margalioth EJ. Prognostic assessment of female fecundity. Lancet (1987) 19:645–647.
Ng EHY, Yeung WSB, Fong DYT, et al. Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility. Hum Reprod (2003) 18:2169–2174.
Ng EH, Chan CCW, Tang OS, et al. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF-treatment. Hum Reprod (2005) 20:1647–1654.
Pache TD, Wladimiroff JW, De Jong FH, et al. Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil Steril (1990) 54:638–642.[Web of Science][Medline]
Ranieri DM, Quinn F, Makhlouf A, et al. Simultaneous evaluation of basal follicle-stimulating hormone and 17 beta-estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve. Fertil Steril (1998) 70:227–233.[CrossRef][Web of Science][Medline]
Reuss ML, Kline J, Santos R, et al. Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol (1996) 174:624–627.[CrossRef][Web of Science][Medline]
Scheffer GJ, Broekmans FJM, Dorland M, et al. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril (1999) 72:845–851.[CrossRef][Web of Science][Medline]
Scheffer GJ, Broekmans FJM, Bancsi LF, et al. Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts. Ultrasound Obstet Gynecol (2002) 20:270–275.[CrossRef][Web of Science][Medline]
Scheffer GJ, Broekmans FJM, Looman CWN, et al. The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod (2003) 18:700–706.
Scott RTJ, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril (1995) 63:1–11.[Web of Science][Medline]
Scott RT, Leonardi MR, Hofmann GE, et al. A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population. Obstet Gynecol (1993) 82:539–544.[Web of Science][Medline]
Soules MR, Battaglia DE, Klein NA. Inhibin and reproductive aging in women. Maturitas (1998) 30:193–204.[CrossRef][Web of Science][Medline]
Syrop CH, Willhoite A, Van Voorhis BJ. Ovarian volume: a novel outcome predictor for assisted reproduction. Fertil Steril (1995) 64:1167–1171.[Web of Science][Medline]
Tanbo T, Dale PO, Lunde O, et al. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril (1992) 57:819–824.[Web of Science][Medline]
Te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update (2002) 8:141–154.
Te Velde ER, Scheffer GJ, Dorland M, et al. Age-dependent changes in serum FSH levels. In: FSH Action and Intraovarian Regulation—Fauser BCJM, Coelingh Bennink HJT, Evers JLH, eds. (1997) UK: Parthenon Publishing Group. 145–155.
Tufan E, Elter K, Durmusoglu F. Assessment of reproductive ageing patterns by hormonal and ultrasonographic ovarian reserve tests. Hum Reprod (2004) 19:2484–2489.
Van der Stege JG, Van der Linden PJ. Useful predictors of ovarian stimulation response in women undergoing in vitro fertilization. Gynecol Obstet Invest (2001) 52:43–46.[CrossRef][Web of Science][Medline]
Van Rooij IAJ, Broekmans FJM, Scheffer GJ, et al. Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril (2005) 83:979–987.[CrossRef][Web of Science][Medline]
Wallace WH, Kelsey TW. Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Hum Reprod (2004) 19:1612–1617.
Weenen C, Laven JSE, Von Bergh ARM, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod (2004) 10:77–83.
Welt CK, Schneyer AL. Differential regulation of inhibin B and inhibin A by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab (2001) 86:330–336.
Welt CK, McNicholl DJ, Taylor AE, et al. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab (1999) 84:105–111.
Winslow KL, Toner JP, Brzyski RG, et al. The gonadotropin-releasing hormone agonist stimulation test – a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril (1991) 56:711–717.[Web of Science][Medline]
Submitted on December 19, 2006; resubmitted on February 22, 2007; accepted on March 5, 2007.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. van Disseldorp, C.B. Lambalk, J. Kwee, C.W.N. Looman, M.J.C. Eijkemans, B.C. Fauser, and F.J. Broekmans Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts Hum. Reprod., October 19, 2009; (2009) dep366v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Deb, M. Batcha, B.K. Campbell, K. Jayaprakasan, J.S. Clewes, J.F. Hopkisson, C. Sjoblom, and N.J. Raine-Fenning The predictive value of the automated quantification of the number and size of small antral follicles in women undergoing ART Hum. Reprod., September 1, 2009; 24(9): 2124 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Broekmans, M. R. Soules, and B. C. Fauser Ovarian Aging: Mechanisms and Clinical Consequences Endocr. Rev., August 1, 2009; 30(5): 465 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.L. Haadsma, H. Groen, V. Fidler, L.H.M. Seinen, F.J.M. Broekmans, M.J. Heineman, and A. Hoek The predictive value of ovarian reserve tests for miscarriage in a population of subfertile ovulatory women Hum. Reprod., March 1, 2009; 24(3): 546 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Jayaprakasan, B.K. Campbell, J.F. Hopkisson, J.S. Clewes, I.R. Johnson, and N.J. Raine-Fenning Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone Hum. Reprod., November 1, 2008; 23(11): 2577 - 2583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.L. Haadsma, H. Groen, V. Fidler, A. Bukman, E.M.A. Roeloffzen, E.R. Groenewoud, F.J.M. Broekmans, M.J. Heineman, and A. Hoek The predictive value of ovarian reserve tests for spontaneous pregnancy in subfertile ovulatory women Hum. Reprod., August 1, 2008; 23(8): 1800 - 1807. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||